Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,907Revenue $M2,595Net Margin (%)6.9Z-Score6.1
Enterprise Value $M4,497EPS $3.2Operating Margin %8.4F-Score7
P/E(ttm))26.8Cash Flow Per Share $4.5Pre-tax Margin (%)8.8Higher ROA y-yY
Price/Book2.810-y EBITDA Growth Rate %3.8Quick Ratio2.7Cash flow > EarningsY
Price/Sales1.85-y EBITDA Growth Rate %10.5Current Ratio2.8Lower Leverage y-yN
Price/Cash Flow13.0y-y EBITDA Growth Rate %42.8ROA % (ttm)7.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)11.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M57.4ROI % (ttm)9.6Gross Margin Increase y-yY

Gurus Latest Trades with CVD

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CVDJoel Greenblatt 2014-03-31 Add0.01%$86.85 - $105.69
($98.65)
$ 88.98-10%Add 33.96%12,886
CVDJoel Greenblatt 2013-12-31 Buy 0.02%$83.45 - $90.51
($86.53)
$ 88.983%New holding, 9619 sh.9,619
CVDVanguard Health Care Fund 2013-06-30 Add0.48%$71.21 - $78.88
($74.79)
$ 88.9819%Add 317.31%2,246,400
CVDVanguard Health Care Fund 2013-03-31 Buy 0.16%$57.77 - $74.32
($67.12)
$ 88.9833%New holding, 538300 sh.538,300
CVDJames Barrow 2012-09-30 Buy 0.07%$46.39 - $49.24
($47.79)
$ 88.9886%New holding, 785725 sh.785,725
CVDJoel Greenblatt 2012-09-30 Sold Out -0.13%$46.39 - $49.24
($47.79)
$ 88.9886%Sold Out0
CVDJoel Greenblatt 2012-06-30 Add0.05%$44.42 - $47.81
($46.14)
$ 88.9893%Add 53.73%38,072
CVDRon Baron 2012-03-31 Reduce-0.09%$43.31 - $49.24
($43.49)
$ 88.98105%Reduce -50%300,000
CVDJoel Greenblatt 2011-12-31 Add0.03%$43.43 - $52.9
($46.97)
$ 88.9889%Add 23.51%26,917
CVDRay Dalio 2011-12-31 Sold Out -0.03%$43.43 - $52.9
($46.97)
$ 88.9889%Sold Out0
CVDJoel Greenblatt 2011-09-30 Add0.1%$44.79 - $62.26
($52.92)
$ 88.9868%Add 143.35%21,794
CVDRay Dalio 2011-09-30 Buy 0.03%$44.79 - $62.26
($52.74)
$ 88.9869%New holding, 45737 sh.45,737
CVDGeorge Soros 2011-06-30 Sold Out $55.92 - $62.6
($59.15)
$ 88.9850%Sold Out0
CVDJoel Greenblatt 2011-06-30 Reduce-0.25%$55.92 - $62.6
($59.15)
$ 88.9850%Reduce -63.28%8,956
CVDJoel Greenblatt 2011-03-31 Add0.29%$50.31 - $58.8
($55.18)
$ 88.9861%Add 249.98%24,390
CVDMario Gabelli 2011-03-31 Sold Out $50.31 - $58.8
($55.18)
$ 88.9861%Sold Out0
CVDGeorge Soros 2011-03-31 Add$50.31 - $58.8
($55.18)
$ 88.9861%Add 43.1%8,300
CVDRon Baron 2011-03-31 Reduce-0.07%$50.31 - $58.8
($55.18)
$ 88.9861%Reduce -29.41%600,000
CVDJoel Greenblatt 2010-12-31 Buy 0.12%$44.38 - $52.61
($47.86)
$ 88.9886%New holding, 6969 sh.6,969
CVDRon Baron 2010-12-31 Reduce-0.35%$44.38 - $52.61
($47.86)
$ 88.9886%Reduce -57.07%850,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CVD is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CVD Vanguard Health Care Fund 2014-06-302,486,0004.330.56+10.67%
CVD Joel Greenblatt 2014-03-3112,8860.020.02+33.96%
CVD Ron Baron 2014-03-31300,0000.520.13
CVD James Barrow 2014-03-31725,7551.260.11-0.55%
Premium Most recent portfolio changes are included for Premium Members only!


CVD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
NUTT BRIAN H.Principal Accounting Officer 2014-02-25Sell210$103.22-17.21view
LOVETT JAMES WCorporate Sr. Vice President 2014-02-20Sell14,955$102.47-16.6view
KLITGAARD WILLIAM ECorporate Sr. Vice President 2014-02-20Sell25,778$101.8-16.05view
WATSON JOHN E.Corp. Sr. Vice President 2014-02-13Sell13,941$100.64-15.08view
Cornell Alison ACorporate VP and CFO 2014-02-12Sell5,554$99.84-14.4view
Cimino Richard FCorp. Executive Vice President 2014-02-10Sell13,000$99.1-13.76view
HELTON SANDRA LDirector 2014-02-10Sell2,800$99.03-13.7view
NUTT BRIAN H.Principal Accounting Officer 2014-02-10Sell1,808$100.12-14.64view
HERRING JOSEPH LChairman and CEO 2014-02-07Sell119,876$97.67-12.5view
Keller Deborah LCorp. Executive Vice President 2014-02-07Sell14,165$98.14-12.92view

Press Releases about CVD :

    Quarterly/Annual Reports about CVD:

    News about CVD:

    Articles On GuruFocus.com
    Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 
    Parexcel: Great Growth but a Tough Business Aug 17 2011 
    Covance Inc. Reports Operating Results (10-K) Feb 28 2011 
    Covance Inc. (CVD) Executive Vice President & COO Wendel Barr sells 13,000 Shares Dec 21 2010 
    Covance Inc. (CVD) Executive Vice President & COO Wendel Barr sells 31,300 Shares Dec 15 2010 
    Covance Inc. (CVD) Executive Vice President & COO Wendel Barr sells 19,305 Shares Nov 22 2010 
    Weekly Guru Bargains Highlights: SD, CREE, AMLN, ICLR, CVD Nov 07 2010 
    Covance Inc. Reports Operating Results (10-Q) Nov 05 2010 
    Weekly Guru Bargains Highlights: Whirlpool Corp, Plexus Corp, Pulte Homes Inc, Owens Corning, Covanc Sep 18 2010 
    Weekly CEO Buys Highlight: Dynex Capital Inc, Helix Energy Solutions Group Inc, Superior Energy Serv Aug 08 2010 

    More From Other Websites
    Covance (CVD) Showing Signs Of Being Water-Logged And Getting Wetter Jul 30 2014
    Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2014 Financial Results Conference... Jul 30 2014
    COVANCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jul 30 2014
    Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2014 Financial Results Conference... Jul 30 2014
    4:16 pm Covance beats by $0.02, beats on revs; guides FY14 EPS in-line Jul 29 2014
    Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of... Jul 29 2014
    Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of... Jul 29 2014
    Q2 2014 Covance Earnings Release - After Market Close Jul 29 2014
    Covance Increases its Medical and Scientific Leadership with Two Senior-Level Appointments Jul 09 2014
    /C O R R E C T I O N -- Covance Inc./ Jul 02 2014
    /C O R R E C T I O N -- Covance Inc./ Jul 02 2014
    Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2014 Financial Results Conference... Jun 25 2014
    Strength Seen in Covidien (CVD): Stock Soars 20.5% Jun 17 2014
    Covance To Present At The William Blair 34th Annual Growth Stock Conference Jun 09 2014
    Covance To Present At The Goldman Sachs 35th Annual Global Healthcare Conference Jun 08 2014
    COVANCE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Jun 06 2014
    Covance To Present At The Jefferies 2014 Global Healthcare Conference Jun 01 2014
    Covance Expands in Market Access May 20 2014
    Covance acquires Medaxial May 19 2014
    Covance Acquires Medaxial May 19 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide